Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-08

Clinical Trial Update: Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized controlled pilot trial evaluating nitrous oxide exposure for sustained mood improvement in treatment-resistant depression and major depressiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: Unity Health Toronto | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 4 | Status: COMPLETED